Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05485324
Other study ID # ?158/23,05,2022
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 24, 2022
Est. completion date July 24, 2022

Study information

Verified date August 2022
Source Bogomolets National Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

in 82.1% of cases it is not possible to achieve a positive result of pain treatment


Description:

The concept of pain treatment in patients with gunshot and mine-explosive injuries and the developed pain relief algorithm at the stages of treatment will have an impact on the results of pain treatment in this category of patients.


Recruitment information / eligibility

Status Completed
Enrollment 2215
Est. completion date July 24, 2022
Est. primary completion date May 24, 2022
Accepts healthy volunteers No
Gender Male
Age group N/A and older
Eligibility Inclusion Criteria: - the presence of gunshot and mine-explosive injuries Exclusion Criteria: - absence of gunshot and mine-explosive injuries

Study Design


Related Conditions & MeSH terms


Intervention

Other:
visual analog scale
Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.

Locations

Country Name City State
Ukraine Bogomolets National Medical University, Ministry of Health of Ukraine Kyiv

Sponsors (1)

Lead Sponsor Collaborator
Bogomolets National Medical University

Country where clinical trial is conducted

Ukraine, 

Outcome

Type Measure Description Time frame Safety issue
Primary visual analog scale from 0 to 10 points 12 months
Primary Didier Bouhassiraa DN4 4 or more points (a neuropathic pain component is present) 12 months
Primary The Hospital Anxiety and Depression Scale 0-7 is the norm 8-13 - mild depressive disorders 14-18 - depressive disorders of medium severity 19-22 - severe depressive disorders 23 and more - depressive disorders of a very severe degree of severity 12 months
Primary Chaban Quality of Life Scale up to 56 inclusive - a very low level 57-66 - low 67-75 - average 76-82 - tall 83-100 is very high 12 months
Primary Mississippi PTSD scale (military version) the mean values of the total score are 76±18 for well-adjusted servicemen, 86±26 for servicemen with mental disorders, and 130±18 for those with PTSD 12 months
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain